Recent Updates
Recently added Catalysts
CERS Positive Sentiment

Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026

Monday, October 19, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Cerus Corporation will announce its third quarter 2026 financial results on November 2, 2026. Following the release, a conference call and webcast will take place at 4:30 P.M. ET, where management will discuss the results and provide a business overview. This event reflects the company's commitment to investor communication.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cerus Corporation is actively engaging with investors.
  • The scheduled conference call indicates transparency in financial reporting.
  • Management will provide insights into the company's outlook.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~61 mo
Minimal dilution risk
Lead asset
S303 Red Blood Cells
Phase 3 · Focus:Use of S303 RBCs in Patients With Acute Anemia

Full Press Release Details

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2026 financial results will be released on Monday, November 2, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relati

Frequently Asked Questions

When will Cerus Corporation release its Q3 2026 results?

Cerus Corporation will release its Q3 2026 financial results on November 2, 2026.

What time is the Cerus conference call scheduled?

The conference call is scheduled for 4:30 P.M. ET on November 2, 2026.

How can I access the Cerus webcast?

You can access the live webcast and presentation slides on the Investor Relations page.

What will be discussed during the conference call?

Management will discuss the financial results and provide a general business overview.

ShareAdd on Google
Tags: CERS Cerus Corporation financial results Q3 2026 conference call
Last updated: Oct 19, 2026

Biotech snapshot

Cash runway
$56M liquidity · $1M/mo burn
~61 mo
Minimal dilution risk
Lead asset
S303 Red Blood CellsPhase 3
Focus:Use of S303 RBCs in Patients With Acute Anemia →